Large-scale testing (Phase 3)Ended earlyNCT00325650What this trial is testingRimonabant In Prediabetic Subjects To Delay Onset Of Type 2 DiabetesWho this might be right forPrediabetic State Sanofi 2,420
Post-approval studies (Phase 4)Looking for participantsNCT06750783What this trial is testingThe Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and PrediabetesWho this might be right forPrediabetic State (IGT) Beijing Tsinghua Chang Gung Hospital 398
Not applicableStudy completedNCT01406665What this trial is testingSkin Autofluorescence (AF) Decision Tree in Detecting Impaired Glucose Tolerance (IGT) or Diabetes Mellitus (DM)Who this might be right forDiabetes MellitusImpaired Glucose Tolerance University Medical Center Groningen 218
Early research (Phase 1)Study completedNCT00348972What this trial is testingLantus in PrediabetesWho this might be right forHyperglycemiaDiabetes Mellitus Sanofi 20
Post-approval studies (Phase 4)Study completedNCT02287402What this trial is testingPostmarketing Clinical Study on AO-128Who this might be right forImpaired Glucose Tolerance (IGT) Takeda 197
Large-scale testing (Phase 3)Study completedNCT01010100What this trial is testingPrevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary CareWho this might be right forDiabetes Mellitus Bayer 204
Post-approval studies (Phase 4)UnknownNCT00733174What this trial is testingRosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose ToleranceWho this might be right forImpaired Glucose Tolerance Denver Research Institute 60
Not applicableStudy completedNCT03650023What this trial is testingA Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGTWho this might be right forNormalImpaired Fasting GlucoseImpaired Glucose Tolerance Yonsei University 37
Testing effectiveness (Phase 2)Study completedNCT01248364What this trial is testingDetermine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy SubjectsWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 91
Testing effectiveness (Phase 2)Study completedNCT00417170What this trial is testingComparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic SyndromeWho this might be right forHigh Blood PressureMetabolic SyndromeInsulin Resistance+1 more Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT00220441What this trial is testingCognitive Effects of Aerobic Exercise for IGT AdultsWho this might be right forImpaired Glucose Tolerance Seattle Institute for Biomedical and Clinical Research 40
Large-scale testing (Phase 3)Study completedNCT00069784What this trial is testingThe ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)Who this might be right forDiabetes Mellitus, Non-Insulin-Dependent Sanofi 12,537
Large-scale testing (Phase 3)Study completedNCT00489229What this trial is testingTo Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsWho this might be right forDiabetesImpaired Glucose Tolerance Universiti Sains Malaysia 66
Post-approval studies (Phase 4)Study completedNCT01219231What this trial is testingEffects of Physical Activity on the Brain in Impaired Glucose Tolerance (IGT)Who this might be right forImpaired Glucose Tolerance Charite University, Berlin, Germany 46
Not applicableLooking for participantsNCT02969798What this trial is testingPre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)Who this might be right forDiabetes Mellitus, Type 2Impaired Glucose Tolerance (IGT)Impaired Fasting Glucose (IFG) The University of Texas Health Science Center at San Antonio 700
Large-scale testing (Phase 3)UnknownNCT00038727What this trial is testingDiabetes Prevention Program Outcomes StudyWho this might be right forDiabetes MellitusCancerCVD National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2,779
Post-approval studies (Phase 4)Study completedNCT03122041What this trial is testingSitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary SyndromeWho this might be right forPCOS University Medical Centre Ljubljana 30
Not applicableStudy completedNCT01456754What this trial is testingEffect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) MenWho this might be right forGlucose Intolerance Maastricht University Medical Center 11
Not applicableStudy completedNCT00816608What this trial is testingThe Effect of Maximum Body Weight in Lifetime on the Development of Type 2 DiabetesWho this might be right forDiabetesPrediabetes Seoul National University Bundang Hospital 3,000
Not applicableUnknownNCT00724542What this trial is testingEvaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.Who this might be right forCoronary Heart DiseaseImpaired Glucose Tolerance Ministry of Science and Technology of the People´s Republic of China 1,600